223 related articles for article (PubMed ID: 22449455)
1. Enhancing crystalline properties of a cardiovascular active pharmaceutical ingredient using a process analytical technology based crystallization feedback control strategy.
Saleemi AN; Steele G; Pedge NI; Freeman A; Nagy ZK
Int J Pharm; 2012 Jul; 430(1-2):56-64. PubMed ID: 22449455
[TBL] [Abstract][Full Text] [Related]
2. Spherical crystallization of drugs.
Kovačič B; Vrečer F; Planinšek O
Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
[TBL] [Abstract][Full Text] [Related]
3. Application of feedback control and in situ milling to improve particle size and shape in the crystallization of a slow growing needle-like active pharmaceutical ingredient.
Yang Y; Pal K; Koswara A; Sun Q; Zhang Y; Quon J; McKeown R; Goss C; Nagy ZK
Int J Pharm; 2017 Nov; 533(1):49-61. PubMed ID: 28935256
[TBL] [Abstract][Full Text] [Related]
4. Development of spherical iron(II) sulfate heptahydrate-containing solid particles with sustained drug release.
Szabó-Révész P; Farkas B; Gregor T; Nagy K; Pallagi E
Eur J Pharm Biopharm; 2007 May; 66(2):193-9. PubMed ID: 17125982
[TBL] [Abstract][Full Text] [Related]
5. Facilitating the use of counter-current chromatography in pharmaceutical purification through use of organic solvent nanofiltration.
Rundquist E; Pink C; Vilminot E; Livingston A
J Chromatogr A; 2012 Mar; 1229():156-63. PubMed ID: 22326182
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of antisolvent crystallization of sodium scutellarein by combined FBRM-PVM-NIR.
Liu X; Sun D; Wang F; Wu Y; Chen Y; Wang L
J Pharm Sci; 2011 Jun; 100(6):2452-9. PubMed ID: 21246557
[TBL] [Abstract][Full Text] [Related]
7. Applications of process analytical technology to crystallization processes.
Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
[TBL] [Abstract][Full Text] [Related]
8. Applications of NIR spectroscopy to monitoring and analyzing the solid state during industrial crystallization processes.
Févotte G; Calas J; Puel F; Hoff C
Int J Pharm; 2004 Apr; 273(1-2):159-69. PubMed ID: 15010140
[TBL] [Abstract][Full Text] [Related]
9. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
Murnane D; Marriott C; Martin GP
Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
[TBL] [Abstract][Full Text] [Related]
10. Analysis of niflumic acid prepared by rapid microwave-assisted evaporation.
Radacsi N; Stefanidis GD; Szabó-Révész P; Ambrus R
J Pharm Biomed Anal; 2014 Sep; 98():16-21. PubMed ID: 24873734
[TBL] [Abstract][Full Text] [Related]
11. Application of direct crystallization for racemic compound propranolol hydrochloride.
Wang X; Lu J; Ching CB
J Pharm Sci; 2007 Oct; 96(10):2735-45. PubMed ID: 17549769
[TBL] [Abstract][Full Text] [Related]
12. Formulation of tablets containing an 'in-process' amorphized active pharmaceutical ingredient.
Jójárt-Laczkovich O; Szabó-Révész P
Drug Dev Ind Pharm; 2011 Nov; 37(11):1272-81. PubMed ID: 21457129
[TBL] [Abstract][Full Text] [Related]
13. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
Murnane D; Marriott C; Martin GP
Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
[TBL] [Abstract][Full Text] [Related]
14. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
Padrela L; Rodrigues MA; Velaga SP; Matos HA; de Azevedo EG
Eur J Pharm Sci; 2009 Aug; 38(1):9-17. PubMed ID: 19477273
[TBL] [Abstract][Full Text] [Related]
15. Applications of NIR in early stage formulation development. Part I. Semi-quantitative blend uniformity and content uniformity analyses by reflectance NIR without calibration models.
Li W; Bashai-Woldu A; Ballard J; Johnson M; Agresta M; Rasmussen H; Hu S; Cunningham J; Winstead D
Int J Pharm; 2007 Aug; 340(1-2):97-103. PubMed ID: 17467204
[TBL] [Abstract][Full Text] [Related]
16. Organic solvents in the pharmaceutical industry.
Grodowska K; Parczewski A
Acta Pol Pharm; 2010; 67(1):3-12. PubMed ID: 20210074
[TBL] [Abstract][Full Text] [Related]
17. The use of FT-NIR for API content assay in organic solvent media: a single calibration for multiple downstream processing streams.
Rodrigues LO; Cardoso JP; Menezes JC
Talanta; 2008 Jun; 75(5):1203-7. PubMed ID: 18585202
[TBL] [Abstract][Full Text] [Related]
18. Use of Wet Milling Combined with Temperature Cycling to Minimize Crystal Agglomeration in a Sequential Antisolvent-Cooling Crystallization.
Sun Z; Quon JL; Papageorgiou CD; Benyahia B; Rielly CD
Cryst Growth Des; 2022 Aug; 22(8):4730-4744. PubMed ID: 35942120
[TBL] [Abstract][Full Text] [Related]
19. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
Almarsson O; Zaworotko MJ
Chem Commun (Camb); 2004 Sep; (17):1889-96. PubMed ID: 15340589
[TBL] [Abstract][Full Text] [Related]
20. Application of precipitation methods for the production of water-insoluble drug nanocrystals: production techniques and stability of nanocrystals.
Xia D; Gan Y; Cui F
Curr Pharm Des; 2014; 20(3):408-35. PubMed ID: 23651396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
